NRx Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for NRX-101 in the Treatment of Chronic Pain kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
NRx has Licensed US Patent 8,653,120 for use of D-Cycloserine to treat Chronic Pain Dr. Vania Apkarian, a world leader in pain and D-Cycloserine research, has joined the NRx Scientific Advisory.
A drug to prevent suicide associated with bipolar depression israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.
RADNOR, Pa., June 20, 2023 /PRNewswire/ NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr.. | June 20, 2023
Item 1.01. Entry into a Material Definitive Agreement.
On June 6, 2023, the Company entered into a securities purchase agreement with the purchasers signatory. | June 7, 2023